132 related articles for article (PubMed ID: 22943179)
1. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
[TBL] [Abstract][Full Text] [Related]
2. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro.
Li M; Li Q; Zhang YH; Tian ZY; Ma HX; Zhao J; Xie SQ; Wang CJ
Anticancer Drugs; 2013 Jan; 24(1):32-42. PubMed ID: 23032518
[TBL] [Abstract][Full Text] [Related]
4. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
5. Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.
Zheng X; Li W; Lan Z; Yang X; Li L; Yuan Y; Xia Z; Chen X; Zhang X; Yu Y
J Pharm Pharmacol; 2015 Nov; 67(11):1593-602. PubMed ID: 26245909
[TBL] [Abstract][Full Text] [Related]
6. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
7. 7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.
Lin B; Chen Z; Xu Y; Zhang H; Liu J; Qian X
Leuk Res; 2011 May; 35(5):646-56. PubMed ID: 21310484
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
[TBL] [Abstract][Full Text] [Related]
9. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
10. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z
Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708
[TBL] [Abstract][Full Text] [Related]
12. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y
Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516
[TBL] [Abstract][Full Text] [Related]
13. [Acetylsalicylic acid strengthens the effects of ANISpm against hepatocellular carcinoma and its molecular mechanism].
Xie SQ; Zhang LL; Yang T; Ma Y; Zhang YH; Li Q; Wang JH; Zhao J; Wang CJ
Yao Xue Xue Bao; 2011 Sep; 46(9):1045-50. PubMed ID: 22121773
[TBL] [Abstract][Full Text] [Related]
14. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
[TBL] [Abstract][Full Text] [Related]
16. Intestinal metabolite compound K of ginseng saponin potently attenuates metastatic growth of hepatocellular carcinoma by augmenting apoptosis via a Bid-mediated mitochondrial pathway.
Song G; Guo S; Wang W; Hu C; Mao Y; Zhang B; Zhang H; Hu T
J Agric Food Chem; 2010 Dec; 58(24):12753-60. PubMed ID: 21121651
[TBL] [Abstract][Full Text] [Related]
17. In vivo and In vitro effect of a nutrient mixture on human hepatocarcinoma cell line SK-HEP-1.
Roomi MW; Roomi NW; Kalinovsky T; Niedzwiecki A; Rath M
Exp Oncol; 2010 Jul; 32(2):84-91. PubMed ID: 20693968
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
19. DHF-18, a new synthetic flavonoid, induced a mitochondrial-mediated apoptosis of hepatocarcinoma cells in vivo and in vitro.
Zhang LB; Qiang L; Chen FH; Wu T; Rong JJ; Zhao Q; Zou MJ; Yang Z; You QD; Li ZY; Wu YL; Guo QL
Eur J Pharmacol; 2011 Jan; 651(1-3):33-40. PubMed ID: 21093431
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
